Vitamin A, Dehydroepiandrosterone (DHEA) and 5’ Nucleotidase: Regulatory Factors in Tumor Growth

References

• DeLuca L M. Essential function deficiency as the result of tumor promotion and the establishment of biological autarchy. Natl Cancer Inst 1983; 70: 405–407
   Google Scholar
• DeLuca L M, Brugh M, Silverman-Jones C S. Retinyl palmitate, retinyl phosphate and dolichyl phosphate of postnuclear fractions from hepatoma, host liver, and regenerating liver: Marginal vitamin A status of hepatoma tissue. Cancer Res 1984; 44: 224–32
   PubMed Web of Science ®Google Scholar
• Merriman R L, Tanzer L R, Stamm N B, et al. Chemoprevention of malignant transformation by dehydroepiandrosterone (DHEA) in C3H10T1/2 cells. 13th Int Cancer Congress ABS 3102. 1982
   Google Scholar
• Schwartz A G. Inhibition of spontaneous breast cancer formation in female C3H-AV6/A mice by long term treatment with dehydroepiandrosterone. Cancer Res 1979; 39: 1129–1132
   PubMed Web of Science ®Google Scholar
• Schwartz A G, Hard G, Pashko L, et al. Dehydroepiandrosterone: An anti-obesity and anti-carcinogenic agent. Nutr Cancer 1981; 3: 46–53
   PubMedGoogle Scholar
• Schwartz A G, Pashko L L, Tannen R H. Dehydroepiandrosterone: An anti-cancer and possible anti-aging substance. Intervention in the Aging Process, Part A: Quantitation, Epidemiology & Clinical Research, W Regelson, M Sinex. Alan R. Liss, New York 1983; 267–278
   Google Scholar
• Schwartz A G, Tannen R H. Inhibition of 7,12-dimethyl benz (a) anthracene and urethan-induced lung tumor formation in A/J mice by long term treatment with dehydroepiandrosterone. Carcinogenesis 1981; 2: 1335–1337
   PubMed Web of Science ®Google Scholar
• Nyce J W, Magee P N, Schwartz A G. Inhibition of 1,2 dimethylhydrazine induced colon cancer in balb/c mice by dehydroepiandrosterone. Proc Assoc Cancer Res 1982; 23: 91
   Web of Science ®Google Scholar
• Henderson E, Schwartz A, Pashko L, et al. Dehydroepiandrosterone and 16 alpha bromo-epiandrosterone: Inhibitors of Epstein-Barr virus induced transformation of human lymphocytes. Carcinogenesis 1981; 2: 683–686
   PubMed Web of Science ®Google Scholar
• Pashko L L, Schwartz A G, Abou-Gharbia M, et al. Inhibition of DNA synthesis in mouse epidermis and breast epithelium by dehydroepiandrosterone and related steroids. Carcinogenesis 1981; 2: 717–721
   PubMed Web of Science ®Google Scholar
• Bulbrook R D, Hayward J L, Spicer C C. Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet 1971; 2: 395–398
   PubMed Web of Science ®Google Scholar
• Ohrentreich N, Brind J L, Rizer R L, et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984; 59: 551–555
   PubMed Web of Science ®Google Scholar
• Riley V. Basic and applied studies on the physiology and pathology of stress. The anti-stress action of dehydroepiandrosterone. M.J. Murdoch Foundation of the late Vernon T. Riley, Pacific Northwest Research Foundation. 1982, Report to the
   Google Scholar
• Tannen R H, Schwartz A C. Reduced weight gain and delay of Coombs positive hemolytic anemia in NZB mice. Fed Proc 1982; 41: 403
   Google Scholar
• Coleman D L, Leiter E A, Schwizer R W. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 1982; 31: 830–833
   PubMed Web of Science ®Google Scholar
• Coleman D L, Schwizer R W, Leiter E H. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes, obesity mutants and in aged normal mice. Diabetes 1984; 33: 26–32
   PubMed Web of Science ®Google Scholar
• Coleman D L, Leiter E H, Applezweig N. Therapeutic effects of dehydroepiandrosterone metabolites in diabetes mutant mice (57BL/KS-db/db). Endocrinology 1984; 115: 1–6
   PubMedGoogle Scholar
• Yen T T, Allan J A, Pearson D V, et al. Prevention of obesity in A-VY/a mice by dehydroepiandrosterone. Lipids 1977; 12: 409–413
   PubMed Web of Science ®Google Scholar
• Cleary M P, Seidensatt R, Tannen R H, et al. The effect of dehydroepiandrosterone on adipose tissue cellularity in mice. Proc Soc Exp Biol Med 1982; 171: 276–284
   PubMed Web of Science ®Google Scholar
• Cleary M P, Shepherd A, Zisk J, et al. Effect of dehydroepiandrosterone on body weight and food intake in rats. Nutr Behav 1983; 1: 127–135
   Google Scholar
• Geary M P, Shepherd A, Jenks B. Effect of dehydroe-piandrosterone on growth of lean and obese Zucker rats. J Nutr 1984; 114: 1242–1251
   PubMed Web of Science ®Google Scholar
• Shepherd A, Geary M P. Metabolic alterations after dehydroe-piandrosterone treatment in Zucker rats. Am J. Physiol 1984; 246: E123–EI28
   PubMed Web of Science ®Google Scholar
• Wynder E L, MacCornak F, Hill P, et al. Nutrition and the etiology and prevention of breast cancer. Cancer Detect Prevent 1976; 1: 293–310
   Google Scholar
• Hill P, Wynder E L. Plasma hormone levels in pre and post menopausal vegetarian women fed a western diet. Fed Proc 1979; 38
   PubMedGoogle Scholar
• Hill P, Wynder E L. Effects of a vegetarian diet and dex-amethasone on plasma prolactin, testosterone and dehydroe-piandrosterone in men and women. Cancer Lett 1979; 7: 273–282
   PubMed Web of Science ®Google Scholar
• Tannenbaum A, Silverstone H. Nutrition in relation to cancer. Adv Cancer Res 1953; 1: 451–501
   PubMed Web of Science ®Google Scholar
• Ross M H, Bras G. Lasting influence of early caloric restriction on prevalance of neoplasms in the rat. J Natl Cancer Inst 1971; 47: 1095–1113
   PubMed Web of Science ®Google Scholar
• Tannenbaum A. The dependence of the genesis of induced skin tumors on the caloric intake during different stages of carcinogenesis. Cancer Res 1944; 4: 673–677
   Google Scholar
• Tannenbaum A, Silverstone H. The influence of the degree of caloric restriction on the formation of tumors and hepatomas in mice. Cancer Res 1949; 9: 724–727
   PubMed Web of Science ®Google Scholar
• Hoffman G, Wenzel F, Oertel G W, et al. Der Stoffwechsel von dehydroepiandrosterone-Lauryl-Sulfate Bei psoriasis. Steroids Lipids Res 1972; 3: 229–239
   PubMedGoogle Scholar
• Weber G. Enzymology of cancer cells. Pt. II. N Eng J Med 1977; 296: 541–551
   PubMed Web of Science ®Google Scholar
• Regelson W, Matus R, MacEwen G. 1985, Work in progress
   Google Scholar
• Orentreich N. Orentreich Foundation for the Adv. Science, Inc. 1984, Report to Donors, Dec
   Google Scholar
• Sun A S, Holland J F, Lin K, et al. Implications of a 5′ nucleotidase inhibitor in human leukemic cells for cellular aging and cancer. Biochem Biophys Acta 1983; 762: 577–584
   PubMed Web of Science ®Google Scholar
• Sun A S, Holland J F, Ohnuma T, et al. 5′Nucleotidase activity in permanent lymphoid cell lines. Implications for cell proliferation and aging in vitro. Biochem Biophys Acta 1982; 714: 530–535
   PubMed Web of Science ®Google Scholar